HU186134B - Process for the production of contraceptive suppository tablets - Google Patents
Process for the production of contraceptive suppository tablets Download PDFInfo
- Publication number
- HU186134B HU186134B HU823211A HU321182A HU186134B HU 186134 B HU186134 B HU 186134B HU 823211 A HU823211 A HU 823211A HU 321182 A HU321182 A HU 321182A HU 186134 B HU186134 B HU 186134B
- Authority
- HU
- Hungary
- Prior art keywords
- parts
- weight
- tablets
- vitamin
- magnesium stearate
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 13
- 239000003433 contraceptive agent Substances 0.000 title claims description 9
- 230000002254 contraceptive effect Effects 0.000 title claims description 8
- 239000000829 suppository Substances 0.000 title 1
- 239000003826 tablet Substances 0.000 claims abstract description 28
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 26
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000004327 boric acid Substances 0.000 claims abstract description 14
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 13
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 13
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 13
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 13
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims abstract description 13
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 13
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 13
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 13
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 13
- 235000002906 tartaric acid Nutrition 0.000 claims abstract description 13
- 239000011975 tartaric acid Substances 0.000 claims abstract description 13
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 11
- 239000008101 lactose Substances 0.000 claims abstract description 11
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 11
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 11
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 11
- 239000000003 vaginal tablet Substances 0.000 claims abstract description 6
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical class [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims abstract description 5
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 claims abstract 8
- 235000012711 vitamin K3 Nutrition 0.000 claims abstract 4
- 239000011652 vitamin K3 Substances 0.000 claims abstract 4
- XDPFHGWVCTXHDX-UHFFFAOYSA-M menadione sodium sulfonate Chemical compound [Na+].C1=CC=C2C(=O)C(C)(S([O-])(=O)=O)CC(=O)C2=C1 XDPFHGWVCTXHDX-UHFFFAOYSA-M 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 6
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims description 3
- 239000004289 sodium hydrogen sulphite Substances 0.000 claims description 2
- 229940044977 vaginal tablet Drugs 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- IIPCTRTZUIMOEC-RJMJUYIDSA-N ethanol (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol Chemical compound CCO.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O IIPCTRTZUIMOEC-RJMJUYIDSA-N 0.000 claims 1
- -1 vitamin sodium bisulfite Chemical class 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 230000001568 sexual effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 6
- 230000003054 hormonal effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 208000015943 Coeliac disease Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 210000003679 cervix uteri Anatomy 0.000 description 2
- 229940124558 contraceptive agent Drugs 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 206010048611 Cholaemia Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241001662043 Icterus Species 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010041969 Steatorrhoea Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000031271 Unwanted pregnancy Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229960004051 menadione sodium bisulfite Drugs 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 208000001162 steatorrhea Diseases 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Absorbent Articles And Supports Therefor (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU823211A HU186134B (en) | 1982-10-07 | 1982-10-07 | Process for the production of contraceptive suppository tablets |
| US06/621,905 US4565694A (en) | 1982-10-07 | 1983-10-07 | Contraceptive vaginal tablets |
| PCT/HU1983/000052 WO1984001502A1 (en) | 1982-10-07 | 1983-10-07 | Contraceptive vaginal tablets and manufacturing method thereof |
| EP83903196A EP0121543B1 (de) | 1982-10-07 | 1983-10-07 | Kontrazeptive scheidentabletten und verfahren zu deren herstellung |
| AU20759/83A AU558286B2 (en) | 1982-10-07 | 1983-10-07 | Contraceptive vaginal tablets and manufacturing method thereof |
| AT83903196T ATE19947T1 (de) | 1982-10-07 | 1983-10-07 | Kontrazeptive scheidentabletten und verfahren zu deren herstellung. |
| DE8383903196T DE3363794D1 (en) | 1982-10-07 | 1983-10-07 | Contraceptive vaginal tablets and manufacturing method thereof |
| JP83503243A JPS59501949A (ja) | 1982-10-07 | 1983-10-07 | 避妊用膣錠およびその製造法 |
| IL70051A IL70051A (en) | 1982-10-07 | 1983-10-26 | Contraceptive vaginal tablets and process for the preparation thereof |
| IN1462/CAL/83A IN162846B (en:Method) | 1982-10-07 | 1983-11-29 | |
| FI842284A FI77781C (fi) | 1982-10-07 | 1984-06-06 | Kontraseptiva (preventiv-) vaginaltabletter och foerfarande foer framstaellning av dessa. |
| DK279184A DK156619C (da) | 1982-10-07 | 1984-06-06 | Kontraceptiv vaginaltablet og fremgangsmaade til dens fremstilling |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU823211A HU186134B (en) | 1982-10-07 | 1982-10-07 | Process for the production of contraceptive suppository tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU186134B true HU186134B (en) | 1985-06-28 |
Family
ID=10963124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU823211A HU186134B (en) | 1982-10-07 | 1982-10-07 | Process for the production of contraceptive suppository tablets |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4565694A (en:Method) |
| EP (1) | EP0121543B1 (en:Method) |
| JP (1) | JPS59501949A (en:Method) |
| AT (1) | ATE19947T1 (en:Method) |
| AU (1) | AU558286B2 (en:Method) |
| DE (1) | DE3363794D1 (en:Method) |
| DK (1) | DK156619C (en:Method) |
| FI (1) | FI77781C (en:Method) |
| HU (1) | HU186134B (en:Method) |
| IL (1) | IL70051A (en:Method) |
| IN (1) | IN162846B (en:Method) |
| WO (1) | WO1984001502A1 (en:Method) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU199615B (en) * | 1986-06-23 | 1990-02-28 | Agardi Mezoegazdasagi Kom | Method and apparatus for pulsation drying granular capillary-porous matters particularly cereals by predried medium |
| IT1213323B (it) * | 1986-08-07 | 1989-12-20 | Crinos Industria Farmaco | Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida |
| US5116619A (en) * | 1988-08-30 | 1992-05-26 | Lee Roy Morgan | Vaginal progesterone tablet |
| WO2006087733A1 (en) * | 2005-01-19 | 2006-08-24 | Kamalinder Kaur Singh | Herbal contraceptive formulations |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3062715A (en) * | 1953-11-18 | 1962-11-06 | George S Pfaus | Vaginal tablet |
| NL272519A (en:Method) * | 1961-12-14 | 1964-08-17 | ||
| US4031202A (en) * | 1975-12-08 | 1977-06-21 | The Procter & Gamble Company | Controlled release contraceptive article |
| DE2602297B1 (de) * | 1976-01-22 | 1977-01-13 | Merz & Co | Vaginalzaepfchen zur empfaengnisverhuetung mit einem gehalt an milchalbumin |
| JPS5845403B2 (ja) * | 1976-02-14 | 1983-10-08 | エーザイ株式会社 | 補酵素ｑを主成分とする膵機能亢進剤 |
| US4242359A (en) * | 1977-04-01 | 1980-12-30 | Cornell Research Foundation, Inc. | Spermicidal agents |
| US4439441A (en) * | 1979-01-11 | 1984-03-27 | Syntex (U.S.A.) Inc. | Contraceptive compositions and methods employing 1-substituted imidazole derivatives |
| US4432967A (en) * | 1982-06-25 | 1984-02-21 | National Starch And Chemical Corp. | Contraceptive composition |
-
1982
- 1982-10-07 HU HU823211A patent/HU186134B/hu not_active IP Right Cessation
-
1983
- 1983-10-07 AU AU20759/83A patent/AU558286B2/en not_active Ceased
- 1983-10-07 JP JP83503243A patent/JPS59501949A/ja active Pending
- 1983-10-07 EP EP83903196A patent/EP0121543B1/de not_active Expired
- 1983-10-07 WO PCT/HU1983/000052 patent/WO1984001502A1/en not_active Ceased
- 1983-10-07 DE DE8383903196T patent/DE3363794D1/de not_active Expired
- 1983-10-07 US US06/621,905 patent/US4565694A/en not_active Expired - Fee Related
- 1983-10-07 AT AT83903196T patent/ATE19947T1/de not_active IP Right Cessation
- 1983-10-26 IL IL70051A patent/IL70051A/xx unknown
- 1983-11-29 IN IN1462/CAL/83A patent/IN162846B/en unknown
-
1984
- 1984-06-06 FI FI842284A patent/FI77781C/fi not_active IP Right Cessation
- 1984-06-06 DK DK279184A patent/DK156619C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK279184A (da) | 1984-06-06 |
| US4565694A (en) | 1986-01-21 |
| EP0121543A1 (en) | 1984-10-17 |
| JPS59501949A (ja) | 1984-11-22 |
| DE3363794D1 (en) | 1986-07-03 |
| IN162846B (en:Method) | 1988-07-16 |
| DK156619C (da) | 1990-02-12 |
| FI842284A0 (fi) | 1984-06-06 |
| ATE19947T1 (de) | 1986-06-15 |
| IL70051A (en) | 1986-12-31 |
| AU558286B2 (en) | 1987-01-22 |
| FI842284A7 (fi) | 1984-06-06 |
| AU2075983A (en) | 1984-05-04 |
| FI77781B (fi) | 1989-01-31 |
| FI77781C (fi) | 1989-05-10 |
| WO1984001502A1 (en) | 1984-04-26 |
| DK156619B (da) | 1989-09-18 |
| EP0121543B1 (de) | 1986-05-28 |
| DK279184D0 (da) | 1984-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Darney et al. | Clinical evaluation of the Capronor contraceptive implant: preliminary report | |
| ES2648640T3 (es) | Anillos intravaginales monolíticos que comprenden progesterona y métodos de fabricación y usos de los mismos | |
| Delbarge et al. | Return to fertility in nulliparous and parous women after removal of the GyneFix® intrauterine contraceptive system | |
| Greydanus et al. | Contraception in the adolescent: Current concepts for the pediatrician | |
| Tietze | History of contraceptive methods | |
| PAUERSTEIN et al. | Factors influencing physiologic activities in the fallopian tube; the anatomy, physiology, and pharmacology of tubal transport | |
| HU186134B (en) | Process for the production of contraceptive suppository tablets | |
| Abrutyn et al. | Teratology study of intravaginally administered nonoxynol-9-containing contraceptive cream in rats | |
| Muasher et al. | Experience with diethylstilbestrol-exposed infertile women in a program of in vitro fertilization | |
| Cox | Clinical Contraception | |
| Urry et al. | Artificial insemination: a comparison of pregnancy rates with intrauterine versus cervical insemination and washed sperm versus serum swim-up sperm preparations | |
| Chaim et al. | Pregnancy with an intrauterine device in situ and preterm delivery | |
| Obrowski et al. | Birth control-current contraception devices and medications: Clinical review | |
| Keche et al. | Sudden Death Due to Rupture of Ectopic Pregnancy in a Young Lactating Mother | |
| Bhatt | Quinacrine nonsurgical female sterilization in Baroda, India: 23 years of follow‐up of 84 women | |
| Jaiswal et al. | Effectiveness and Safety of Levonorgestrel Intrauterine Device in Abnormal Uterine Bleeding, Adenomyosis and Perimenopausal Bleeding Patients. | |
| NZ206039A (en) | Contraceptive vaginal tablets containing boric acid and vitamin k3 | |
| Haspels | Post-coital interception | |
| Haspels et al. | New aspects in post-coital contraception | |
| Guttmacher | The Contraceptive Problem | |
| Bitzer | Hormonal and Non-hormonal Contraceptives | |
| Andros | Intrauterine contraceptive devices | |
| Krzaniak | Unilateral tubal twin pregnancy | |
| Sharman | A new synthetic oral oestrogen | |
| 陈蔚琳 et al. | Contraceptive vaginal ring (NuvaRing)-a novel, convenient and effective contraceptive option |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HU90 | Patent valid on 900628 | ||
| HMM4 | Cancellation of final prot. due to non-payment of fee |